Cargando…
Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A
Prostacyclin (PGI(2)) controls platelet activation and thrombosis through a cyclic adenosine monophosphate (cAMP) signaling cascade. However, in patients with cardiovascular diseases this protective mechanism fails for reasons that are unclear. Using both pharmacological and genetic approaches we de...
Autores principales: | Berger, Martin, Raslan, Zaher, Aburima, Ahmed, Magwenzi, Simbarashe, Wraith, Katie S., Spurgeon, Benjamin E.J., Hindle, Matthew S., Law, Robert, Febbraio, Maria, Naseem, Khalid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049344/ https://www.ncbi.nlm.nih.gov/pubmed/31289200 http://dx.doi.org/10.3324/haematol.2018.213348 |
Ejemplares similares
-
Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation
por: Berger, Martin, et al.
Publicado: (2018) -
Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014) -
Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability
por: Yusuf, M. Z., et al.
Publicado: (2017) -
The Spatiotemporal Regulation of cAMP Signaling in Blood Platelets—Old Friends and New Players
por: Raslan, Zaher, et al.
Publicado: (2015) -
Rectal Hyposensitivity
por: Burgell, Rebecca E, et al.
Publicado: (2012)